Published in Mol Cell Biol on March 16, 2015
eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis. Oncogene (2016) 0.81
mTORC1 Plays an Important Role in Skeletal Development by Controlling pre-Osteoblast Differentiation. Mol Cell Biol (2017) 0.75
Signal Integration at Elongation Factor 2 Kinase; the Roles of Calcium, Calmodulin and Ser-500 Phosphorylation. J Biol Chem (2016) 0.75
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science (2005) 38.99
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell (2002) 18.22
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol (1997) 15.32
Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science (1997) 7.07
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell (2003) 6.76
Cellular mechanisms of muscle fatigue. Physiol Rev (1994) 4.92
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res (2009) 4.50
Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J (2001) 4.40
Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature (1992) 4.12
Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J (2007) 3.28
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell (2013) 2.74
Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature (1988) 2.71
Acidity generated by the tumor microenvironment drives local invasion. Cancer Res (2013) 2.63
A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J (2001) 2.60
Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov (2011) 2.45
A hierarchy of ATP-consuming processes in mammalian cells. Biochem J (1995) 2.32
ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK. Oncogene (1999) 2.30
4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev (2005) 2.28
Tumor pH and its measurement. J Nucl Med (2010) 2.08
A formula for correlating pKa values determined in D2O and H2O. J Inorg Biochem (2004) 2.07
A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol Cell Biol (2004) 1.88
An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol (1975) 1.83
Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol (2006) 1.76
Functional properties of phosphorylated elongation factor 2. Eur J Biochem (1990) 1.75
Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol (2010) 1.59
pH sensing and regulation in cancer. Front Physiol (2013) 1.33
Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress. Sci Signal (2012) 1.23
Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling. J Biol Chem (2012) 1.20
Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem (1998) 1.19
Mapping the functional domains of elongation factor-2 kinase. Biochemistry (2000) 1.19
Stable isotope-labelling analysis of the impact of inhibition of the mammalian target of rapamycin on protein synthesis. Biochem J (2012) 1.17
Manipulating tumor acidification as a cancer treatment strategy. Altern Med Rev (2010) 1.15
Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism. J Biol Chem (1999) 1.11
Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol Biol Cell (1995) 1.10
Abnormalities in protein synthesis and degradation induced by extracellular pH in BC3H1 myocytes. Am J Physiol (1991) 1.08
Regulation of elongation factor-2 kinase by pH. Biochemistry (2002) 1.05
N-methyl-D-aspartate receptor activation and visual activity induce elongation factor-2 phosphorylation in amphibian tecta: a role for N-methyl-D-aspartate receptors in controlling protein synthesis. Proc Natl Acad Sci U S A (1997) 1.05
Regulation of mTORC1 signaling by pH. PLoS One (2011) 1.04
Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase. Biochem J (2012) 1.03
Oxygen sensing by H+: implications for HIF and hypoxic cell memory. Cell Cycle (2004) 1.01
1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J Biol Chem (2011) 1.00
Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains. Biochem J (2012) 0.95
Regulation of dendritic spine growth through activity-dependent recruitment of the brain-enriched Na⁺/H⁺ exchanger NHE5. Mol Biol Cell (2011) 0.92
Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Mol Cell Biol (2014) 0.89
Nuclear magnetic resonance studies of trypsin inhibitors. Histidines of virgin and modified soybean trypsin inhibitor (Kunitz). Biochemistry (1973) 0.85
Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia. Mol Cell Biol (2015) 0.85
Intracellular and extracellular tumor pH measurement in a series of patients with oral cancer. J Craniofac Surg (2007) 0.84
Signaling crosstalk between the mTOR complexes. Translation (Austin) (2014) 0.80
The activation of brain adenylate cyclase and brain cyclic-nucleotide phosphodiesterase by seven calmodulin derivatives. Eur J Biochem (1980) 0.78
Acidosis-induced p38 MAPK activation and its implication in regulation of cardiac contractility. Acta Pharmacol Sin (2004) 0.76
Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Mol Cell Biol (2014) 0.89
Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia. Mol Cell Biol (2015) 0.85